Table 8 Variables associated with benzodiazepine use during the most recent treatment period for anxiety disordersb, c
From: Treatment adequacy of anxiety disorders among young adults in Finland
Benzodiazepine prescribed | |||
|---|---|---|---|
Variable | Category | OR | 95 % CI |
Gender | Male (ref.) | 1.00 | - |
Female | 0.66 | 0.16–2.63 | |
Basic education | Less than high school (ref.) | 1.00 | - |
High school | 1.46 | 0.37–5.81 | |
Married or | No (ref.) | 1.00 | - |
cohabiting | Yes | 0.94 | 0.29–3.08 |
Comorbid | No (ref.) | 1.00 | - |
mood disorder | Yes | 0.66 | 0.20–2.21 |
Comorbid substance | No (ref.) | 1.00 | - |
use disorder | Yes | 2.30 | 0.57–9.26 |
Comorbid | No (ref.) | 1.00 | - |
personality disorder | Yes | *4.77 | 1.11–20.59 |
Comorbid | No (ref.) | 1.00 | - |
other disordera | Yes | 1.72 | 0.39–7.47 |
More than 1 anxiety | No (ref.) | 1.00 | - |
disorder | Yes | 0.45 | 0.08–2.65 |